McKesson (MCK) Q3 2024 Earnings Call Transcript
MCK earnings call for the period ending December 31, 2023.
Source: yahoo.com
Kesson Venture News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Kesson Venture. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Kesson Venture Today - Breaking & Trending Today
McKesson Corporation (NYSE:MCK) Q3 2024 Earnings Call Transcript
McKesson Corporation (NYSE:MCK) Q3 2024 Earnings Call Transcript February 7, 2024 McKesson Corporation misses on earnings expectations. Reported EPS is $4.42 EPS, expectations were $7.05. McKesson Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to McKesson’s Third Quarter […]
Source: yahoo.com
McKesson Corporation (NYSE:MCK) Q3 2024 Earnings Call Transcript
McKesson Corporation misses on earnings expectations. Reported EPS is $4.42 EPS, expectations were $7.05.
Source: insidermonkey.com
Clinical Ink launches Lunexis ePRO+ platform module
Clinical Ink launches Lunexis ePRO+ platform module The clinical trial tech firm has enhanced its electronic patient-reported outcome module, and landed an investment to help promote various technologies. Clinical Ink has announced enhancements to its Lunexis ePRO+ electronic patient-reported outcome module. The module is part of the company’s unified trial technology platform, which reportedly helps streamline implementation and gives both patients and sites the ability to choose which devices they use to participate in a study: smartphone, tablet or web. “P a...
Source: outsourcing-pharma.com